ELECTROPHYSIOLOGIC EFFECTS OF LORCAINIDE ON THE ACCESSORY PATHWAY IN THE WOLFF-PARKINSON-WHITE SYNDROME

被引：8

作者：

KASPER, W ^{[1
]}

TREESE, N ^{[1
]}

MEINERTZ, T ^{[1
]}

JAHNCHEN, E ^{[1
]}

POP, T ^{[1
]}

机构：

[1] UNIV MAINZ,INST PHARMAKOL,D-6500 MAINZ,FED REP GER

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1983年 / 51卷 / 10期

关键词：

D O I：

10.1016/0002-9149(83)90197-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1618 / 1622

页数：5

共 14 条

[1]

BAR FW, 1981, BRIT HEART J, V45, P292

[2]

CARMELIET E, 1978, ARCH INT PHARMACOD T, V231, P104

[3] INITIAL CLINICAL EXPERIENCE OF LORCAINIDE (RO 13-1042), A NEW ANTIARRHYTHMIC AGENT [J].

COCCO, G ;

STROZZI, C .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) :105-109

[4]

JAHNCHEN E, 1979, CLIN PHARMACOL THER, V26, P187

[5] ELECTRO-PHYSIOLOGICAL ACTIONS OF LORCAINIDE IN PATIENTS WITH CARDIAC DISEASE [J].

KASPER, W ;

MEINERTZ, T ;

KERSTING, F ;

LOLLGEN, H ;

LANG, K ;

JUST, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (03) :343-352

[6] RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED CROSSOVER TRIAL DOCUMENTING ORAL LORCAINIDE EFFICACY IN SUPPRESSION OF SYMPTOMATIC VENTRICULAR TACHYARRHYTHMIAS [J].

KEEFE, DL ;

PETERS, F ;

WINKLE, RA .

AMERICAN HEART JOURNAL, 1982, 103 (04) :511-518

[7]

KESTELOOT H, 1977, ARCH INT PHARMACOD T, V230, P225

[8]

MANZ M, 1982, EUR HEART J, V3, P55

[9]

MEINERTZ T, 1982, Z KARDIOL, V71, P35

[10]

MEINERTZ T, 1979, CLIN PHARMACOL THER, V26, P196

← 1 2 →